HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefania Gobessi Selected Research

ZAP-70 Protein-Tyrosine Kinase (ZAP 70 Protein Tyrosine Kinase)

12/2007Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
11/2005Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefania Gobessi Research Topics

Disease

9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2019 - 11/2005
5Neoplasms (Cancer)
01/2019 - 07/2006
3Disease Progression
10/2019 - 11/2005
2Lymphoma (Lymphomas)
01/2018 - 03/2007
2Leukemia
03/2015 - 08/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018
1Wiskott-Aldrich Syndrome
02/2013
1Reinfection
02/2013
1Autoimmune Diseases (Autoimmune Disease)
06/2012
1Rheumatoid Arthritis
04/2009
1Melanoma (Melanoma, Malignant)
07/2006
1Testicular Neoplasms (Testicular Cancer)
07/2006

Drug/Important Bio-Agent (IBA)

5AntigensIBA
03/2015 - 07/2006
2Agammaglobulinaemia Tyrosine KinaseIBA
10/2019 - 02/2014
2Phosphotransferases (Kinase)IBA
08/2012 - 07/2009
2ZAP-70 Protein-Tyrosine Kinase (ZAP 70 Protein Tyrosine Kinase)IBA
12/2007 - 11/2005
1Chemokine ReceptorsIBA
10/2019
1ibrutinibIBA
10/2019
1Auranofin (Ridaura)FDA Link
01/2019
1Prednisone (Sone)FDA LinkGeneric
01/2018
1Rituximab (Mabthera)FDA Link
01/2018
1AntibodiesIBA
01/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
1Vincristine (Oncovin)FDA LinkGeneric
01/2018
1venetoclaxIBA
01/2016
1Sirtuin 1IBA
08/2015
1Proteins (Proteins, Gene)FDA Link
02/2013
1Aurora KinasesIBA
08/2012
1tozasertibIBA
08/2012
1SurvivinIBA
08/2012
1Interleukin-2 (IL2)IBA
08/2012
1OligonucleotidesIBA
08/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2012
1CPG-oligonucleotideIBA
09/2010
1Syk KinaseIBA
07/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2009
1Antigen Receptors (Antigen Receptor)IBA
12/2007
1Immunoglobulin Variable RegionIBA
12/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2007
1trichostatin A (A 300)IBA
07/2006
1Biological ProductsIBA
07/2006
1Small Interfering RNA (siRNA)IBA
07/2006
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2005
1Indicators and Reagents (Reagents)IBA
11/2005
1Messenger RNA (mRNA)IBA
11/2005

Therapy/Procedure

2Therapeutics
01/2019 - 01/2018
1Ligation
02/2014